SAN DIEGO, Calif., Feb. 8, 2000 (PRIMEZONE) -- Charles Kallmann, chief executive officer and president of Hydrogiene Corporation (OTCBB:HICS), reported today that its independent auditors are in final stages of completion of the Company's books and records that when completed, will allow filing of its 8 k, as well as SB-2 registration with the SEC. Delay in completion of the audit due to finalization of the Company's acquisition of the Decurion Corporation.
The Company's ten million dollar SB-2 filing, as well as commitment from the investment group providing the money are standing ready to proceed as soon as SEC approval is received.
The Company's Medigard anti-bacterial development program continues on track with completion still looking at mid April. Upon completion of laboratory and in-house testing, patent applications will be filed and an independent test laboratory will commence its testing and validation process.
Kallmann also stated Hydrogiene's intention to establish a Hydrogiene Medical and Scientific Advisory Board consisting of credentialed doctors and scientists to assist the company in its ongoing anti-bacterial research and ongoing developments.
National Brokers & Distributors President, John Aguero responsible for national and international sales activities for Hydrogiene has advised delivery forecasts will be shortly in place with first Mediclenze and Theraclenze deliveries in late April to markets scheduled for initial penetration based on ADI research data.
Hydrogiene will announce in April names of first mass retailers who will take on Hydrogiene's Theraclenze line of Intimate Personal Hygiene, Water Therapy and Sitz Bath products with co op advertising beginning in mid April.
A revised, independent Financial Market Research Report will be forth coming scheduled for March. Currently, the existing FMR may be obtained by calling Hydrogiene's Investor Services at 877-374-9376 or by clicking on Hydrogiene is a Public Company at its website www. hydrogiene.com.
Safe Harbor for Forward-Looking Statements: Except for historical information contained herein, the statements in this news release are forward looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Reform Act of 1995. Forward-Looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to differ from forecasted results.